• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终结艾滋病:HIV 感染即慢性病。

The end of AIDS: HIV infection as a chronic disease.

机构信息

Department of Medicine, University of California, San Francisco, CA, USA.

出版信息

Lancet. 2013 Nov 2;382(9903):1525-33. doi: 10.1016/S0140-6736(13)61809-7. Epub 2013 Oct 23.

DOI:10.1016/S0140-6736(13)61809-7
PMID:24152939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4058441/
Abstract

The success of antiretroviral therapy has led some people to now ask whether the end of AIDS is possible. For patients who are motivated to take therapy and who have access to lifelong treatment, AIDS-related illnesses are no longer the primary threat, but a new set of HIV-associated complications have emerged, resulting in a novel chronic disease that for many will span several decades of life. Treatment does not fully restore immune health; as a result, several inflammation-associated or immunodeficiency complications such as cardiovascular disease and cancer are increasing in importance. Cumulative toxic effects from exposure to antiretroviral drugs for decades can cause clinically-relevant metabolic disturbances and end-organ damage. Concerns are growing that the multimorbidity associated with HIV disease could affect healthy ageing and overwhelm some health-care systems, particularly those in resource-limited regions that have yet to develop a chronic care model fully. In view of the problems inherent in the treatment and care for patients with a chronic disease that might persist for several decades, a global effort to identify a cure is now underway.

摘要

抗逆转录病毒疗法的成功使得一些人开始询问艾滋病是否可能被终结。对于那些有动力接受治疗并能够获得终身治疗的患者来说,艾滋病相关疾病不再是主要威胁,而是出现了一系列新的与 HIV 相关的并发症,导致一种新的慢性疾病,许多人将在未来几十年的生命中与之共存。治疗并不能完全恢复免疫健康;因此,一些与炎症或免疫缺陷相关的并发症,如心血管疾病和癌症,变得越来越重要。数十年来接触抗逆转录病毒药物所产生的累积毒性作用可导致临床上显著的代谢紊乱和终末器官损伤。人们越来越担心,与 HIV 疾病相关的多种合并症可能会影响健康老龄化,并使一些卫生保健系统不堪重负,特别是在资源有限的地区,这些地区尚未完全建立慢性护理模式。鉴于可能持续数十年的慢性疾病患者的治疗和护理所固有的问题,目前正在全球范围内努力寻找治愈方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6782/4058441/dd4599e6640f/nihms587074f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6782/4058441/221421b77cd3/nihms587074f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6782/4058441/dd4599e6640f/nihms587074f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6782/4058441/221421b77cd3/nihms587074f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6782/4058441/dd4599e6640f/nihms587074f2.jpg

相似文献

1
The end of AIDS: HIV infection as a chronic disease.终结艾滋病:HIV 感染即慢性病。
Lancet. 2013 Nov 2;382(9903):1525-33. doi: 10.1016/S0140-6736(13)61809-7. Epub 2013 Oct 23.
2
[HIV infection and AIDS in advanced age. Epidemiological and clinical issues, and therapeutic and management problems].[老年人群中的HIV感染与艾滋病。流行病学与临床问题,以及治疗与管理难题]
Infez Med. 2004 Sep;12(3):152-73.
3
Tuberculosis结核病
4
HIV and aging: time for a new paradigm.HIV 与衰老:是时候建立新的范式了。
Curr HIV/AIDS Rep. 2010 May;7(2):69-76. doi: 10.1007/s11904-010-0041-9.
5
Chronic Disease Onset Among People Living with HIV and AIDS in a Large Private Insurance Claims Dataset.大型私人保险理赔数据集中国内艾滋病毒/艾滋病患者慢性病发病情况。
Sci Rep. 2019 Dec 6;9(1):18514. doi: 10.1038/s41598-019-54969-3.
6
Human immunodeficiency virus infection, Part I.人类免疫缺陷病毒感染,第一部分。
Dis Mon. 1998 Oct;44(10):545-606. doi: 10.1016/s0011-5029(98)90014-1.
7
Human immunodeficiency virus in an aging population, a complication of success.老龄化人口中的人类免疫缺陷病毒,成功的并发症。
J Am Geriatr Soc. 2009 Nov;57(11):2129-38. doi: 10.1111/j.1532-5415.2009.02494.x. Epub 2009 Sep 28.
8
HIV disease and advanced age: an increasing therapeutic challenge.HIV疾病与高龄:日益严峻的治疗挑战。
Drugs Aging. 2002;19(9):647-69. doi: 10.2165/00002512-200219090-00003.
9
Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings.抗逆转录病毒疗法对资源有限环境下HIV-1传播及艾滋病死亡率的潜在影响。
J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):632-41. doi: 10.1097/01.qai.0000194234.31078.bf.
10
[The 14th International Aids Conference: 'Knowledge, commitment and action'].[第十四届国际艾滋病大会:“知识、承诺与行动”]
Ned Tijdschr Geneeskd. 2002 Oct 5;146(40):1899-903.

引用本文的文献

1
The Effects of Cobicistat and Voriconazole on the Safety, Pharmacokinetics, and Pharmacodynamics of the TLR7 Agonist Vesatolimod in People with HIV.考比司他和伏立康唑对HIV感染者中TLR7激动剂维沙托利莫德的安全性、药代动力学及药效学的影响。
Infect Dis Ther. 2025 Sep 15. doi: 10.1007/s40121-025-01227-x.
2
A 30-Year Epidemiological Study of Opportunistic Fungal Infections in People Living with HIV in Greece: Associations with Demographic Characteristics and Immune Status.希腊HIV感染者机会性真菌感染的30年流行病学研究:与人口统计学特征和免疫状态的关联
J Clin Med. 2025 Aug 22;14(17):5936. doi: 10.3390/jcm14175936.
3
DLCO in HIV Patients and Their Association with CD4 and VL.

本文引用的文献

1
Increase in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trial.拉替拉韦强化治疗治疗后 2 长末端重复环增加和 D-二聚体减少:一项随机、安慰剂对照试验。
J Infect Dis. 2013 Nov 1;208(9):1436-42. doi: 10.1093/infdis/jit453. Epub 2013 Aug 23.
2
HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation.HIV 复制会改变外源性凝血途径凝血因子的组成,并增加凝血酶生成。
J Am Heart Assoc. 2013 Jul 29;2(4):e000264. doi: 10.1161/JAHA.113.000264.
3
Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.
HIV患者的一氧化碳弥散量及其与CD4和病毒载量的关联。
HIV AIDS (Auckl). 2025 Sep 2;17:277-285. doi: 10.2147/HIV.S532629. eCollection 2025.
4
Gestational exposure to HIV drugs alters intestinal mucosa-associated microbial diversity in adult rat offspring.孕期接触抗HIV药物会改变成年大鼠后代肠道黏膜相关微生物的多样性。
Exp Biol Med (Maywood). 2025 Aug 13;250:10564. doi: 10.3389/ebm.2025.10564. eCollection 2025.
5
Cannabis Use Moderates Methamphetamine- and HIV-Related Inflammation: Evidence from Human Plasma Markers.大麻使用可减轻与甲基苯丙胺和艾滋病毒相关的炎症:来自人体血浆标志物的证据。
Viruses. 2025 Aug 20;17(8):1143. doi: 10.3390/v17081143.
6
Myocardial Infarction in Young Adults: A Case Series and Comprehensive Review of Molecular and Clinical Mechanisms.年轻成年人的心肌梗死:病例系列及分子与临床机制的综合综述
Biomolecules. 2025 Jul 23;15(8):1065. doi: 10.3390/biom15081065.
7
Genetic and molecular landscape of comorbidities in people living with HIV.HIV感染者共病的遗传和分子格局
Nat Med. 2025 Aug 20. doi: 10.1038/s41591-025-03887-1.
8
Mechanistic insights and HIV suppression by the BRD4-targeting small molecule ZL0580.靶向BRD4的小分子ZL0580的作用机制及对HIV的抑制作用
bioRxiv. 2025 Aug 14:2025.08.14.670267. doi: 10.1101/2025.08.14.670267.
9
Dolutegravir + lamivudine effectiveness and tolerability in real-world cohorts with HIV-1 across Asia and South America: A systematic literature review.多替拉韦+拉米夫定在亚洲和南美洲HIV-1真实世界队列中的有效性和耐受性:一项系统文献综述
Medicine (Baltimore). 2025 Aug 15;104(33):e43558. doi: 10.1097/MD.0000000000043558.
10
No associations between HIV reservoir and inflammation in long-term virally suppressed dolutegravir-based ART-treated individuals.在长期病毒抑制的基于多替拉韦的抗逆转录病毒治疗个体中,HIV储存库与炎症之间无关联。
Front Immunol. 2025 Jul 28;16:1628086. doi: 10.3389/fimmu.2025.1628086. eCollection 2025.
美国各亚人群中的人类免疫缺陷病毒护理和治疗差异。
JAMA Intern Med. 2013 Jul 22;173(14):1337-44. doi: 10.1001/jamainternmed.2013.6841.
4
Response to the AIDS pandemic--a global health model.应对艾滋病大流行——一种全球健康模式。
N Engl J Med. 2013 Jun 6;368(23):2210-8. doi: 10.1056/NEJMra1201533.
5
Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.在可能治愈的干预措施期间检测 HIV 持续存在的挑战:柏林患者研究。
PLoS Pathog. 2013;9(5):e1003347. doi: 10.1371/journal.ppat.1003347. Epub 2013 May 9.
6
Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.南非开始抗逆转录病毒治疗的成年人的预期寿命:队列研究的协作分析。
PLoS Med. 2013;10(4):e1001418. doi: 10.1371/journal.pmed.1001418. Epub 2013 Apr 9.
7
Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening.低成本实现良好健康 25 年:加强卫生系统的未来经验教训。
Lancet. 2013 Jun 15;381(9883):2118-33. doi: 10.1016/S0140-6736(12)62000-5. Epub 2013 Apr 8.
8
Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy.在接受有效抗逆转录病毒治疗的 HIV 1 型感染成年人中,功能障碍与炎症和免疫激活相关。
J Infect Dis. 2013 Jul 15;208(2):249-59. doi: 10.1093/infdis/jit147. Epub 2013 Apr 4.
9
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.早期启动抗逆转录病毒治疗中断后实现长期病毒学缓解的治疗后HIV-1控制者:ANRS VISCONTI研究
PLoS Pathog. 2013 Mar;9(3):e1003211. doi: 10.1371/journal.ppat.1003211. Epub 2013 Mar 14.
10
The immunomodulatory nutritional intervention NR100157 reduced CD4+ T-cell decline and immune activation: a 1-year multicenter randomized controlled double-blind trial in HIV-infected persons not receiving antiretroviral therapy (The BITE Study).免疫调节营养干预 NR100157 可减少 CD4+ T 细胞下降和免疫激活:未接受抗逆转录病毒治疗的 HIV 感染者的 1 年多中心随机对照双盲试验(BITE 研究)。
Clin Infect Dis. 2013 Jul;57(1):139-46. doi: 10.1093/cid/cit171. Epub 2013 Mar 19.